American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · Sep 2018
Randomized Controlled Trial Multicenter StudyEffects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial.
Cystic fibrosis (CF) is characterized by dietary antioxidant deficiencies, which may contribute to an oxidant-antioxidant imbalance and oxidative stress. ⋯ Antioxidant supplementation was safe and well tolerated, resulting in increased systemic antioxidant concentrations and modest reductions in systemic inflammation after 4 weeks. Antioxidant treatment was also associated with a lower risk of first pulmonary exacerbation. Clinical trial registered with www.clinicaltrials.gov (NCT01859390).
-
Am. J. Respir. Crit. Care Med. · Sep 2018
Randomized Controlled Trial Multicenter StudyTelemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial.
Early detection of chronic obstructive pulmonary disease (COPD) exacerbations using telemonitoring of physiological variables might reduce the frequency of hospitalization. ⋯ In older patients with COPD and comorbidities, remote monitoring of lung function by forced oscillation technique and cardiac parameters did not change TTFH and EQ-5D. Clinical trial registered with www.clinicaltrials.gov (NCT 01960907).
-
Am. J. Respir. Crit. Care Med. · Sep 2018
Randomized Controlled TrialEfficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
We examined whether increased rifampin doses could shorten standard therapy for tuberculosis without increased toxicity. ⋯ Our findings of more rapid sputum sterilization and similar toxicity with higher rifampin doses support investigation of increased rifampin doses to shorten tuberculosis treatment. Clinical trial registered with www.clinicaltrials.gov (NCT 01408914) .